# A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

> **NCT03000608** · PHASE2 · COMPLETED · sponsor: **Santalis Pharmaceuticals, Inc.** · enrollment: 69 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** SAN021 Serum
- **DRUG:** SAN021 Placebo

## Key facts

- **NCT ID:** NCT03000608
- **Lead sponsor:** Santalis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-17
- **Primary completion:** 2017-12-13
- **Final completion:** 2017-12-14
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2019-05-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03000608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03000608, "A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03000608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*